Encapsulating Peritoneal Sclerosis: Case report and Current Status

Journal Title: Archives of Clinical Nephrology - Year 2017, Vol 3, Issue 2

Abstract

Encapsulating peritoneal sclerosis (EPS), is a rare but devastating complication of long-term peritoneal dialysis (PD) with a high mortality rate. The incidence is between 0.5 and 3.3%, decreasing with time. EPS is defined as a clinical syndrome with major signs of gastrointestinal obstruction, inflammatory parameters, radiological and macroscopic changes. Duration of treatment and cessation of PD are the main risk for development of EPS: about 75% of EPS occurred in patients transferred on hemodialysis or in the two years after kidney transplantation. Morphological alterations are disappearance of mesothelial layer, sub-mesothelial fibrosis, interstitial sclerosis and vasculopathy, ultrafiltration failure, fast transport status of the peritoneal membrane, and loss of sodium sieving are the most predicting functional abnormalities. Some biomarkers could be found in the peritoneal effluent. The pathophysiology is probably a consequence of a multiple-hit process in which expression of growth factors and cytokines play a role. Medical strategies (corticosteroids, immunosuppressive drugs, tamoxifen) in association with parenteral nutrition and/or surgery (enterolysis) are discussed. Prevention is the use of physiological peritoneal solutions, icodextrine instead of high glucose concentration solution, and peritoneal lavage after peritoneal dialysis cessation for any reason.

Authors and Affiliations

Rottembourg Jacques, Issad Belkacem

Keywords

Related Articles

ANCA-Associated Vasculitis in Patient with CREST-Syndrome - Case Report

Background: ANCA-associated vasculitis is a small vessel necrotizing vasculitis with few or no immune deposits, necrotizing glomerulonephritis is very common in the microscopic poliangiitis subset. Systemic scleroderma r...

Encapsulating Peritoneal Sclerosis: Case report and Current Status

Encapsulating peritoneal sclerosis (EPS), is a rare but devastating complication of long-term peritoneal dialysis (PD) with a high mortality rate. The incidence is between 0.5 and 3.3%, decreasing with time. EPS is defin...

Peritoneal catheter survival: The impact of unroofing

Background: Unroofing is a controversial procedure to avoid catheter removal in the treatment of the chronic exit site and tunnel infection, but is now rarely recommended. Here we aimed to evaluate the effects of the unr...

Acute Renal Failure in Sarcoidosis: A Review of the Literature

We report two cases of acute kidney failure (ARF) as the initial manifestation of sarcoidosis. Two patients were sent from their primary care physicians with hypercalcemia and progressive increase of serum creatinine. Th...

Echinocandins and Continuous Renal Replacement Therapies: The Role of Adsorption

The following reviews [1,2], about continuous renal replacement therapies (CRRT) and echinocandins conclude that the membranes do not significantly adsorb these antifungals.

Download PDF file
  • EP ID EP344984
  • DOI 10.17352/acn.000025
  • Views 73
  • Downloads 0

How To Cite

Rottembourg Jacques, Issad Belkacem (2017). Encapsulating Peritoneal Sclerosis: Case report and Current Status. Archives of Clinical Nephrology, 3(2), 39-46. https://europub.co.uk/articles/-A-344984